Compound: Ropivacaine
SMILES: O=C(Nc1c(cccc1C)C)[C@H]2N(CCCC2)CCC
InChIKey: ZKMNUMMKYBVTFN-HNNXBMFYSA-N
Synonyms: Ropivacaine, 84057-95-4, (S)-Ropivacaine, Ropivacaina, Ropivacainum, (2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide, Ropivicaine, 7IO5LYA57N, TLC590, (-)-1-Propyl-2',6'-pipecoloxylidide, TLC-590, L-N-n-propylpipecolic acid-2,6-xylidide, CHEBI:8890, (S)-(-)-1-propyl-2',6'-pipecoloxylidide, DTXSID4040187, 1-propyl-2',6'-pipecoloxylidide, AL-381, (-)-1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilid, LEA-103, CHEBI:60802, RefChem:55986, LEA103, DTXCID2020187, N01BB09, 1 Propyl 2',6' pipecoloxylidide, AL381, 617-525-1, 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, Ropivacaine [INN], (S)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide, Ropivacaina [Spanish], Ropivacaine base, MFCD00864425, Ropivacainum [INN-Latin], Ropivacaina [INN-Spanish], (2S)-N-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide, S-Ropivacaine, Ropivacaine (INN), Noropine, Narop, Naropin (TN), NCGC00164597-01, Ropivacaine [INN:BAN], UNII-7IO5LYA57N, LEA 103, 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, (2S)-, Ropivacaine (Standard), (2S)-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide, ROPIVACAINE [MI], ROPIVACAINE [VANDF], SCHEMBL33292, ROPIVACAINE [USP-RS], ROPIVACAINE [WHO-DD], BIDD:GT0203, Narop; Noropine; LEA-103, GTPL7602, orb1310661, orb3025113, CHEMBL1077896, HY-B0563R, ZKMNUMMKYBVTFN-HNNXBMFYSA-N, ALBB-038629, HY-B0563, MSK10272, BBL102321, EBC-03920, s5504, STL556120, T0386L, AKOS017343283, CCG-267197, DB00296, AS-35173, DA-48865, FR178417, SY102338, CS-0009514, NS00001426, R0251, C07532, D08490, AB00698466-07, AB00698466_10, EN300-7436767, Q279504, (S)-(-)-1-PROPYL-2',6'-PIPECOLOXYLIDINE, BRD-K50938786-003-11-8, (-)-1-propyl-2',6'-dimethyl-2-piperidylcarboxyanilide, Z2235811359, (s)-n-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide, (S)-(-)-1-PROPYLPIPERIDINE-2-CARBOXYLIC ACID (2,6-DIMETHYLPHENYL)AMIDE
Theoretical properties:
molecular_formula: C17H26N2O
molecular_weight: 274.4 g/mol
exact_mass: 274.204513457 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 1
hydrogen_bond_acceptor_count: 2
rotatable_bond_count: 4
heavy_atom_count: 20
topological_polar_surface_area: 32.3 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
pubchem: (S)-ropivacaine is a piperidinecarboxamide-based amide-type local anaesthetic (amide caine) in which (S)-N-propylpipecolic acid and 2,6-dimethylaniline are combined to form the amide bond. It has a role as a local anaesthetic. It is a piperidinecarboxamide and a ropivacaine.
chebi: A piperidinecarboxamide-based amide-type local anaesthetic (amide caine) in which (<i>S</i>)-<em>N</em>-propylpipecolic acid and 2,6-dimethylaniline are combined to form the amide bond.
chembl: ROPIVACAINE is a small molecule listed in the ChEMBL database and has reached clinical trial phase 4.0.
wikipedia: Ropivacaine (rINN) is a local anaesthetic drug belonging to the amino amide group. The name ropivacaine refers to both the racemate and the marketed S-enantiomer. Ropivacaine hydrochloride is commonly marketed by AstraZeneca under the brand name Naropin.